Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas

NCT00766753 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
22
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Frank Lieberman

Collaborators